{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:22:08Z","timestamp":1791883328611,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,3,31]],"date-time":"2013-03-31T00:00:00Z","timestamp":1364688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s12149-013-0718-4","type":"journal-article","created":{"date-parts":[[2013,3,30]],"date-time":"2013-03-30T07:08:56Z","timestamp":1364627336000},"page":"538-545","source":"Crossref","is-referenced-by-count":94,"title":["Physiological and tumoral uptake of 68Ga-DOTATATE: standardized uptake values and challenges in interpretation"],"prefix":"10.1007","volume":"27","author":[{"given":"Serkan","family":"Kuyumcu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep G\u00f6zde","family":"\u00d6zkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Sanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Mudun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isik","family":"Adalet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seher","family":"Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,31]]},"reference":[{"key":"718_CR1","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.apradiso.2012.03.032","volume":"70","author":"E Blom","year":"2012","unstructured":"Blom E, Koziorowski J. 68Ga-autoclabeling of DOTA-TATE and DOTA-NOC. Appl Radiat Isot. 2012;70:980\u20133.","journal-title":"Appl Radiat Isot"},{"key":"718_CR2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","volume":"48","author":"D Kendler","year":"2007","unstructured":"Kendler D, Dobrozemsky G, Heute D, Uprimny C, et al. 68Ga-DOTA-Tyr3-octreotide PET in NET: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med. 2007;48:508\u201318.","journal-title":"J Nucl Med"},{"key":"718_CR3","doi-asserted-by":"crossref","unstructured":"Kowalski J, Henze M, Schuhmacher J, Macke HR, Hofmann M, Haberkorn U. Evaluation of positron emission tomography imaging using [68Ga]- DOTA-D Phe(1)-Tyr(3)-octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with NET. Mol Imaging Biol. 2003;5:42\u20138.","DOI":"10.1016\/S1536-1632(03)00038-6"},{"key":"718_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.beem.2007.01.007","volume":"21","author":"F Forrer","year":"2007","unstructured":"Forrer F, Valkema R, Kwekkeboom DJ, de Jong M, Krenning EP. NET. Peptide receptor radionuclide therapy. Best Pract Res Clin Endocrinol Metab. 2007;21:111\u201329.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"718_CR5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002590050034","volume":"27","author":"JC Reubi","year":"2000","unstructured":"Reubi JC, Sch\u00e4r JC, Waser B, Wenger S, Heppeler A, Schmitt JS, et al. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med. 2000;27(3):273\u201382.","journal-title":"Eur J Nucl Med"},{"issue":"11","key":"718_CR6","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/RLU.0b013e31825b2555","volume":"37","author":"J Kunikowska","year":"2012","unstructured":"Kunikowska J, Kr\u00f3licki L, Pawlak D, Zerizer I, Miko\u0142ajczak R. Semiquantitative Analysis and Characterization of Physiological Biodistribution of 68Ga-DOTATATE PET\/CT. Clin Nucl Med. 2012;37(11):1052\u20137.","journal-title":"Clin Nucl Med"},{"issue":"9","key":"718_CR7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12149-012-0628-x","volume":"26","author":"S Kuyumcu","year":"2012","unstructured":"Kuyumcu S, Adalet I, Sanli Y, Turkmen C, Ozkan ZG, Yilmazbayhan D. Somatostatin receptor scintigraphy with (111)In-octreotide in pulmonary carcinoid tumors correlated with pathological and (18)FDG PET\/CT findings. Ann Nucl Med. 2012;26(9):689\u201397.","journal-title":"Ann Nucl Med"},{"key":"718_CR8","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00259-007-0450-1","volume":"34","author":"I Buchmann","year":"2007","unstructured":"Buchmann I, Henze M, Engelbrecht S, Buchmann I, Henze M, Engelbrecht S, et al. Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (OctreoScan) SPECT in patients with NET. Eur J Nucl Med Mol Imaging. 2007;34:1617\u201326.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"718_CR9","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/cncr.23469","volume":"112","author":"I Kayani","year":"2008","unstructured":"Kayani I, Bomanji JB, Groves A, Conway G, Gacinovic S, Win T, et al. Functional imaging of NET with combined PET\/CT using 68Ga-DOTATATE (DOTA-DPhe(1), Tyr(3)-octreotate) and 18F-FDG. Cancer. 2008;112:2447\u201355.","journal-title":"Cancer"},{"key":"718_CR10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","volume":"48","author":"M Gabriel","year":"2007","unstructured":"Gabriel M, Decristoforo C, Kendler D, Dobrozemsky G, Heute D, Uprimny C, et al. 68Ga-DOTATyr3-octreotide PET in NET: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med. 2007;48:508\u201318.","journal-title":"J Nucl Med"},{"key":"718_CR11","author":"D Putzer","year":"2012","unstructured":"Putzer D, Kroiss A, Waitz D, Gabriel M, Traub-Weidinger T, Uprimny C, et al. Somatostatin receptor PET in neuroendocrine tumors: (68)Ga-DOTA (0), Tyr (3)-octreotide versus (68)Ga-DOTA (0)-lanreotide. Eur J Nucl Med Mol Imaging. 2012. doi: 10.1007\/s00259-012-2286-6 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"718_CR12","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.2967\/jnumed.111.091165","volume":"52","author":"TD Poeppel","year":"2011","unstructured":"Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, et al. 68Ga-DOTATOC versus 68Ga-DOTATATE PET\/CT in functional imaging of NET. J Nucl Med. 2011;52(12):1864\u201370.","journal-title":"J Nucl Med"},{"key":"718_CR13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.dld.2009.07.018","volume":"42","author":"V Zamora","year":"2010","unstructured":"Zamora V, Cabanne A, Salanova R, Bestani C, Domenichini E, Marmissolle F, et al. Immunohistochemical expression of somatostatin receptors in digestive endocrine tumors. Dig Liver Dis. 2010;42:220\u20135.","journal-title":"Dig Liver Dis"},{"issue":"Suppl 1","key":"718_CR14","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1007\/s00259-011-2019-2","volume":"39","author":"G Pepe","year":"2012","unstructured":"Pepe G, Moncayo R, Bombardieri E, Chiti A. Somatostatin receptor SPECT. Eur J Nucl Med Mol Imaging. 2012;39(Suppl 1):S41\u201351.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"718_CR15","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00259-011-1846-5","volume":"38","author":"D Kaemmerer","year":"2011","unstructured":"Kaemmerer D, Peter L, Lupp A, Schulz S, S\u00e4nger J, Prasad V, et al. Molecular imaging with 68Ga-SSTR PET\/CT and correlation to immunohistochemistry of somatostatin receptors in NET. Eur J Nucl Med Mol Imaging. 2011;38:1659\u201368.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"718_CR16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2967\/jnumed.109.066134","volume":"51","author":"R Srirajaskanthan","year":"2010","unstructured":"Srirajaskanthan R, Kayani I, Quigley AM, Soh J, Caplin ME, Bomanji J. The role of 68Ga-DOTATATE PET in patients with NET and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy. J Nucl Med. 2010;51(6):875\u201382.","journal-title":"J Nucl Med"},{"issue":"11","key":"718_CR17","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.2967\/jnumed.111.101675","volume":"53","author":"AR Haug","year":"2012","unstructured":"Haug AR, Cindea-Drimus R, Auernhammer CJ, Reincke M, W\u00e4ngler B, Uebleis C, et al. The role of 68Ga-DOTATATE PET\/CT in suspected NET. J Nucl Med. 2012;53(11):1686\u201392.","journal-title":"J Nucl Med"},{"issue":"8","key":"718_CR18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00259-012-2123-y","volume":"39","author":"L Kabasakal","year":"2012","unstructured":"Kabasakal L, Demirci E, Ocak M, Decristoforo C, Araman A, Ozsoy Y, et al. Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET\/CT imaging in the same patient group with NET. Eur J Nucl Med Mol Imaging. 2012;39(8):1271\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"718_CR19","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00259-011-1760-x","volume":"38","author":"C Boy","year":"2011","unstructured":"Boy C, Heusner TA, Poeppel TD, Redmann-Bischofs A, Unger N, Jentzen W, et al. 68Ga-DOTATOC PET\/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax. Eur J Nucl Med Mol Imaging. 2011;38(7):1224\u201336.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"718_CR20","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/MNM.0b013e32833f635e","volume":"31","author":"M Shastry","year":"2010","unstructured":"Shastry M, Kayani I, Wild D, Caplin M, Visvikis D, Gacinovic S, et al. Distribution pattern of 68Ga-DOTATATE in disease-free patients. Nucl Med Commun. 2010;31(12):1025\u201332.","journal-title":"Nucl Med Commun"},{"issue":"1","key":"718_CR21","first-page":"61","volume":"54","author":"V Prasad","year":"2010","unstructured":"Prasad V, Baum RP. Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with NET: characterization of uptake in normal organs and tumor lesions. Q J Nucl Med Mol Imaging. 2010;54(1):61\u20137.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"1","key":"718_CR22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/RLU.0b013e3182393404","volume":"37","author":"Y Krausz","year":"2012","unstructured":"Krausz Y, Rubinstein R, Appelbaum L, Mishani E, Orevi M, Fraenkel M, et al. Ga-68 DOTA-NOC uptake in the pancreas: pathological and physiological patterns. Clin Nucl Med. 2012;37(1):57\u201362.","journal-title":"Clin Nucl Med"},{"issue":"6","key":"718_CR23","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2967\/jnumed.111.088328","volume":"52","author":"P Castellucci","year":"2011","unstructured":"Castellucci P, Pou Ucha J, Fuccio C, Rubello D, Ambrosini V, Montini GC, et al. Incidence of increased 68Ga-DOTANOC uptake in the pancreatic head in a large series of extrapancreatic NET patients studied with sequential PET\/CT. J Nucl Med. 2011;52(6):886\u201390.","journal-title":"J Nucl Med"},{"issue":"12","key":"718_CR24","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s002590100639","volume":"28","author":"M Hofmann","year":"2001","unstructured":"Hofmann M, Maecke H, B\u00f6rner R, Weckesser E, Sch\u00f6ffski P, Oei L, et al. Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data. Eur J Nucl Med. 2001;28(12):1751\u20137.","journal-title":"Eur J Nucl Med"},{"issue":"5","key":"718_CR25","first-page":"1865","volume":"6","author":"S Schulz","year":"2000","unstructured":"Schulz S, Pauli SU, Schulz S, H\u00e4ndel M, Dietzmann K, Firsching R, et al. Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin Cancer Res. 2000;6(5):1865\u201374.","journal-title":"Clin Cancer Res"},{"key":"718_CR26","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01084376","volume":"23","author":"S Inanir","year":"1996","unstructured":"Inanir S, Unlu M, Okudan B, Cila E, Atik S. Indium-111 octreotide scintigraphy in patients with bone tumours of the extremities. Eur J Nuc Med. 1996;23:987\u201390.","journal-title":"Eur J Nuc Med"},{"issue":"2","key":"718_CR27","first-page":"238","volume":"39","author":"CC Chen","year":"1998","unstructured":"Chen CC, Czerwiec FS, Feuillan PP. Visualization of fibrous dysplasia during somatostatin receptor scintigraphy. J Nucl Med. 1998;39(2):238\u201340.","journal-title":"J Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-013-0718-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-013-0718-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-013-0718-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T18:35:48Z","timestamp":1644690948000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-013-0718-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,31]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["718"],"URL":"https:\/\/doi.org\/10.1007\/s12149-013-0718-4","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,31]]}}}